z-logo
Premium
Surface antigen expression on bladder tumor cells induced by bacillus Calmette‐Guérin (BCG): A role of BCG internalization into tumor cells
Author(s) -
IKEDA NORIKO,
TOIDA ICHIRO,
IWASAKI AKIO,
KAWAI KOJI,
AKAZA HIDEYUKI
Publication year - 2002
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2002.00415.x
Subject(s) - cd80 , antigen , medicine , interferon gamma , cytotoxic t cell , major histocompatibility complex , cancer research , mhc class i , tumor antigen , immunology , immunotherapy , cd40 , in vitro , cytokine , biology , immune system , biochemistry
Background: The antitumor mechanisms of bacillus Calmette‐Guérin (BCG) against bladder cancer is still unclear. We previously reported that BCG was internalized by and survived within murine bladder tumor cells (MBT‐2) for at least 40 days. In the present study, we investigated the effect of BCG on the surface antigen expression of bladder tumor cells and the characteristics of these cells as antigen‐presenting cells in vitro . Methods: Surface antigen (major histocompatibility complex (MHC) Class II, CD1, CD80 and intercellular adhesion molecule‐1 (ICAM‐1)) expression on BCG‐treated murine (MBT‐2) and human (T‐24, J82) bladder tumor cells were analyzed using flow cytometry. The production of interleukin‐2 (IL‐2) and interferon‐γ (IFN‐γ) from murine lymphocytes sensitized with BCG or BCG‐treated tumor cells were also investigated. Results: The expressions of MHC Class II, CD1, CD80 and ICAM‐1 were augmented in all of the bladder tumor cell lines used; however, they were augmented to varying degrees among the cell lines that were treated with live BCG. Heat‐killed BCG had little or no effect. When murine lymph node cells sensitized with BCG or BCG‐treated MBT‐2 cells were cocultured with BCG‐treated MBT‐2 cells, significant amounts of IL‐2 and IFN‐γ were produced in the culture medium. Conclusions: BCG induced the augmented expression of surface antigens, such as MHC Class II, CD1, CD80 and ICAM‐1, of bladder tumor cells. Furthermore, BCG‐treated MBT‐2 cells could stimulate BCG‐sensitized lymphocytes to produce IL‐2 and IFN‐γ. These results strongly suggest that bladder tumor cells gained the characteristics and functions of antigen‐presenting cells (APC).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here